Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
D'Addario
Stephen
S
Carrington
Patrick R
PR
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000634:Aminoquinolines / Q000009:adverse effects* / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D000077271:Imiquimod; D007636:Keratoacanthoma / Q000139:chemically induced* / Q000473:pathology; D007642:Keratosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014466:Ultraviolet Rays / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod